Estimated 10-year cardiovascular mortality seriously underestimates overall cardiovascular risk

被引:48
|
作者
Jorstad, Harald T. [1 ]
Colkesen, Ersen B. [1 ]
Boekholdt, S. Matthijs [1 ]
Tijssen, Jan G. [1 ]
Wareham, Nicholas J. [2 ]
Khaw, Kay-Tee [3 ]
Peters, Ron J. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1100 DD Amsterdam, Netherlands
[2] Addenbrookes Hosp, Epidemiol Unit, MRC, Inst Metab Sci, Cambridge, England
[3] Univ Cambridge, Dept Publ Hlth & Primary Care, Inst Publ Hlth, Cambridge, England
基金
英国医学研究理事会;
关键词
CORONARY-HEART-DISEASE; PRIMARY PREVENTION; EPIC-NORFOLK; PRIMARY-CARE; GUIDELINES; SURVIVAL; ASPIRIN; HEALTH; TRENDS; SCORE;
D O I
10.1136/heartjnl-2015-307668
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective The European Society of Cardiology's prevention guideline suggests that the risk of total (fatal plus non-fatal) cardiovascular disease (CVD) may be calculated from the risk of CVD mortality using a fixed multiplier (3x). However, the proposed multiplier has not been validated. We investigated the ratio of total CVD to CVD mortality in a large population-based cohort. Methods CVD mortality and total CVD (fatal plus non-fatal CVD requiring hospitalisation) were analysed using Kaplan-Meier estimates among 24014 men and women aged 39-79 years without baseline CVD or diabetes mellitus in the prospective population-based European Prospective Investigation of Cancer and Nutrition-Norfolk cohort. CVD outcomes included death and hospitalisations for ischaemic heart disease, heart failure, cerebrovascular disease, peripheral artery disease or aortic aneurysm. The main study outcome was the ratio of 10-year total CVD to 10-year CVD mortality stratified by age and sex. Results Ten year CVD mortality was 3.9% (900 CVD deaths, 95% CI 3.6% to 4.1%); the rate of total CVD outcomes was 21.2% (4978 fatal or non-fatal CVD outcomes, 95% CI 20.7% to 21.8%). The overall ratio of total CVD to CVD mortality was 5.4. However, we found major differences in this ratio when stratified by gender and age. In young women (39-50years), the ratio of total CVD to CVD mortality was 28.5, in young men (39-50years) 11.7. In the oldest age group, these ratios were considerably lower (3.2 in women and 2.4 in men aged 75-79years). Conclusions The relationship between 10-year total CVD and CVD mortality is dependent on age and sex, and cannot be estimated using a fixed multiplier. Using CVD mortality to estimate total CVD risk leads to serious underestimation of risk, particularly in younger age groups, and particularly in women.
引用
收藏
页码:63 / 68
页数:6
相关论文
共 50 条
  • [21] Trends in Cardiovascular Disease Risk Factor Prevalence and Estimated 10-Year Cardiovascular Risk Scores in a Large Untreated French Urban Population: The CARVAR 92 Study
    Karam, Carma
    Beauchet, Alain
    Czernichow, Sebastien
    de Roquefeuil, Florence
    Bourez, Alain
    Mansencal, Nicolas
    Dubourg, Olivier
    PLOS ONE, 2015, 10 (04):
  • [22] Do the 2017 blood pressure cut-offs improve 10-year cardiovascular disease mortality risk prediction?
    Peng, Yang
    Wang, Zhiqiang
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2020, 30 (11) : 2008 - 2016
  • [23] Performance of the Framingham risk models and pooled cohort equations for predicting 10-year risk of cardiovascular disease: a systematic review and meta-analysis
    Damen, Johanna A.
    Pajouheshnia, Romin
    Heus, Pauline
    Moons, Karel G. M.
    Reitsma, Johannes B.
    Scholten, Rob J. P. M.
    Hooft, Lotty
    Debray, Thomas P. A.
    BMC MEDICINE, 2019, 17 (1)
  • [24] Estimation of cardiovascular risk using 10-year risk metric: time for a rethink?
    Kalhan, Atul
    Rees, Alan
    CURRENT OPINION IN LIPIDOLOGY, 2012, 23 (04) : 402 - 403
  • [25] Arterial elasticity and oxidized LDL among men with metabolic syndrome and different 10-year cardiovascular risk estimated by FINRISK and SCORE models
    Pohjantahti-Maaroos, Hanna
    Palomaki, Ari
    Kankkunen, Paivi
    Husgafvel, Sari
    Knuth, Timo
    Vesterinen, Kai
    Oksanen, Kalevi
    ANNALS OF MEDICINE, 2012, 44 (05) : 503 - 512
  • [26] Relative Validity of the 10-Year Cardiovascular Risk Estimate in a Population Cohort of the REGICOR Study
    Marrugat, Jaume
    Vila, Joan
    Miguel Baena-Diez, Jose
    Grau, Maria
    Sala, Joan
    Ramos, Rafel
    Subirana, Isaac
    Fito, Montserrat
    Elosua, Roberto
    REVISTA ESPANOLA DE CARDIOLOGIA, 2011, 64 (05): : 385 - 394
  • [27] Estimating 10-year cardiovascular disease risk in Asian patients with schizophrenia
    Rekhi, Gurpreet
    Khyne, Toe Toe
    Lee, Jimmy
    GENERAL HOSPITAL PSYCHIATRY, 2016, 43 : 46 - 50
  • [28] Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease
    Pandya, Ankur
    Sy, Stephen
    Cho, Sylvia
    Weinstein, Milton C.
    Gaziano, Thomas A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (02): : 142 - 150
  • [29] Metabolic syndrome and cardiovascular risk assessment tools' estimations of 10-year cardiovascular risk: a population-based study
    Motamed, Nima
    Rabiee, Behnam
    Roozafzai, Farzin
    Zamani, Farhad
    Faraji, Amir Hossein
    Maadi, Mansooreh
    Keyvani, Hossein
    Khonsari, Mahmood Reza
    Hemasi, Gholam Reza
    ACTA CARDIOLOGICA, 2018, 73 (05) : 439 - 446
  • [30] Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease: Results From the Cooper Center Longitudinal Study
    Abdullah, Shuaib M.
    Defina, Laura F.
    Leonard, David
    Barlow, Carolyn E.
    Radford, Nina B.
    Willis, Benjamin L.
    Rohatgi, Anand
    McGuire, Darren K.
    de Lemos, James A.
    Grundy, Scott M.
    Berry, Jarett D.
    Khera, Amit
    CIRCULATION, 2018, 138 (21) : 2315 - 2325